Loading...
Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study
AIMS: Dipeptidyl-peptidase-4 inhibitors (DPP-4i) have been implicated with an increased pancreatic cancer risk. We therefore compared pancreatic cancer incidence and diagnostic work-up among initiators of DPP-4i versus sulfonylureas (SU) and thiazolidinediones (TZD). METHODS: Medicare claims data we...
Na minha lista:
| Udgivet i: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4227935/ https://ncbi.nlm.nih.gov/pubmed/25109825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12379 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|